Alzheimer’s Disease: The Way Forward

Alzheimer’s Disease: The Way Forward

Alzheimer’s Disease: The Way Forward Last week, we reviewed the pathology and genetics of Alzheimer’s disease (AD), and discussed the two most common AD drug development targets, amyloid-beta plaques and tau. This week, we’ll take a look at a variety of novel AD drug...
Alzheimer’s Disease: A Tough Nut To Crack

Alzheimer’s Disease: A Tough Nut To Crack

Alzheimer’s disease: A tough nut to crack September 21 is World Alzheimer’s Day, a day focused on raising awareness of Alzheimer’s disease (AD). This week and next, we’ll review what is known about AD, and summarize novel treatments in development. Alzheimer’s...
Attacking All Angles Of Alzheimer’s

Attacking All Angles Of Alzheimer’s

Alzheimer’s Pipeline Roundup Alzheimer’s disease ranks as one of the toughest nuts to crack within drug discovery and development. Current treatments merely manage symptoms, so finding a better solution becomes more and more urgent as the aging population grows....